![]() |
|
|
Molecular Pharmacology, Vol 11, 79-86, Copyright © 1975 by the American Society for Pharmacology and Experimental Therapeutics
1 Department of Biological Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel
Epinephrine and carbamylcholine, which cause K+ release in rat parotid slices, also
increase the incorporation of 32Pi into phosphatidylinositol. The effects of epinephrine
on K+ release and 32Pi incorporation were inhibited by phentolamine but not by
atropine, whereas the effects of carbamylcholine were inhibited by atropine but not by
phentolamine. Epinephrine at 20 µM caused a half-maximal increase in the incorporation
of 32Pi into phosphatidylinositol; this is similar to the value previously determined for the
alpha adrenergic response of K+ release. Induction of massive enzyme secretion by
isoproterenol of N6,O2'-dibutyryladenosine 3',5'-monophosphate (dibutyryl cyclic AMP)
had no effect on the incorporation of 32Pi. No changes in the composition of the major
phospholipids of the parotid gland were observed. The epinephrine-induced K+ release
was dependent upon calcium and reached a steady state within 5 min. On the other hand,
the increased incorporation of 32Pi into phosphatidylinositol showed a lag of about 10
min, was inhibited by Ca2+, and was maximally increased in the presence of ethylene
glycol bis(
-aminoethyl ether)-N,N'-tetraacetic acid. It is concluded that the K+ release
is neither a prerequisite for nor the direct result of the increased incorporation of 32Pi into
phosphatidylinositol.